MX2010008103A - Metodo para optimizar el tratamiento de enfermedades proliferativas mediadas por el receptor de cinasa de tirosina kit con imatinib. - Google Patents
Metodo para optimizar el tratamiento de enfermedades proliferativas mediadas por el receptor de cinasa de tirosina kit con imatinib.Info
- Publication number
- MX2010008103A MX2010008103A MX2010008103A MX2010008103A MX2010008103A MX 2010008103 A MX2010008103 A MX 2010008103A MX 2010008103 A MX2010008103 A MX 2010008103A MX 2010008103 A MX2010008103 A MX 2010008103A MX 2010008103 A MX2010008103 A MX 2010008103A
- Authority
- MX
- Mexico
- Prior art keywords
- tyrosine kinase
- proliferative diseases
- imatinib
- optimizing
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a un método para el tratamiento de las enfermedades proliferativas mediadas por el receptor de cinasa de tirosina KIT, en particular tumores estromales gastrointestinales (GIST), en una población de pacientes humanos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2294508P | 2008-01-23 | 2008-01-23 | |
PCT/US2009/031510 WO2009094360A1 (en) | 2008-01-23 | 2009-01-21 | Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor kit with imatinib |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010008103A true MX2010008103A (es) | 2010-08-23 |
Family
ID=40435094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010008103A MX2010008103A (es) | 2008-01-23 | 2009-01-21 | Metodo para optimizar el tratamiento de enfermedades proliferativas mediadas por el receptor de cinasa de tirosina kit con imatinib. |
Country Status (14)
Country | Link |
---|---|
US (3) | US20100298338A1 (es) |
EP (1) | EP2237783B1 (es) |
JP (2) | JP5936821B2 (es) |
KR (1) | KR101579993B1 (es) |
CN (1) | CN101951910B (es) |
AU (1) | AU2009206566A1 (es) |
BR (1) | BRPI0906504A2 (es) |
CA (1) | CA2712087A1 (es) |
ES (1) | ES2526537T3 (es) |
MX (1) | MX2010008103A (es) |
PL (1) | PL2237783T3 (es) |
PT (1) | PT2237783E (es) |
RU (1) | RU2537223C2 (es) |
WO (1) | WO2009094360A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2753391C1 (ru) * | 2020-09-29 | 2021-08-13 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ оптимизации лечения стромальных опухолей желудочно-кишечного тракта |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7125875B2 (en) * | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
GB0127922D0 (en) * | 2001-11-21 | 2002-01-16 | Novartis Ag | Organic compounds |
SG139747A1 (en) * | 2003-11-18 | 2008-02-29 | Novartis Ag | Inhibitors of the mutant form of kit |
US7329495B2 (en) * | 2004-06-09 | 2008-02-12 | Board Of Regents, The University Of Texas System | Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors |
MY148074A (en) * | 2005-05-10 | 2013-02-28 | Novartis Ag | Pharmaceutical compositions comprising imatinib and a release retardant |
ATE495761T1 (de) * | 2006-09-22 | 2011-02-15 | Novartis Ag | Optimierung der behandlung philadelphia-positiver leukämie mit abl-tyrosinkinasehemmer imatinib |
KR20090083918A (ko) | 2006-11-07 | 2009-08-04 | 노파르티스 아게 | 알리스키렌 헤미푸마레이트의 결정질 형태 |
-
2009
- 2009-01-21 BR BRPI0906504-0A patent/BRPI0906504A2/pt not_active IP Right Cessation
- 2009-01-21 WO PCT/US2009/031510 patent/WO2009094360A1/en active Application Filing
- 2009-01-21 AU AU2009206566A patent/AU2009206566A1/en not_active Abandoned
- 2009-01-21 CA CA2712087A patent/CA2712087A1/en not_active Abandoned
- 2009-01-21 KR KR1020107018386A patent/KR101579993B1/ko not_active IP Right Cessation
- 2009-01-21 JP JP2010544393A patent/JP5936821B2/ja active Active
- 2009-01-21 EP EP09704256.8A patent/EP2237783B1/en not_active Revoked
- 2009-01-21 PL PL09704256T patent/PL2237783T3/pl unknown
- 2009-01-21 ES ES09704256.8T patent/ES2526537T3/es active Active
- 2009-01-21 MX MX2010008103A patent/MX2010008103A/es active IP Right Grant
- 2009-01-21 CN CN2009801027282A patent/CN101951910B/zh not_active Expired - Fee Related
- 2009-01-21 PT PT97042568T patent/PT2237783E/pt unknown
- 2009-01-21 RU RU2010134916/15A patent/RU2537223C2/ru not_active IP Right Cessation
- 2009-01-21 US US12/863,627 patent/US20100298338A1/en not_active Abandoned
-
2013
- 2013-12-18 JP JP2013261728A patent/JP5881671B2/ja active Active
-
2015
- 2015-10-27 US US14/924,207 patent/US20160045501A1/en not_active Abandoned
-
2016
- 2016-10-19 US US15/297,372 patent/US9763944B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2011510086A (ja) | 2011-03-31 |
KR101579993B1 (ko) | 2015-12-23 |
WO2009094360A1 (en) | 2009-07-30 |
CN101951910A (zh) | 2011-01-19 |
CN101951910B (zh) | 2013-07-17 |
EP2237783B1 (en) | 2014-11-19 |
RU2537223C2 (ru) | 2014-12-27 |
RU2010134916A (ru) | 2012-02-27 |
EP2237783A1 (en) | 2010-10-13 |
ES2526537T3 (es) | 2015-01-13 |
US20160045501A1 (en) | 2016-02-18 |
US20100298338A1 (en) | 2010-11-25 |
PL2237783T3 (pl) | 2015-04-30 |
JP2014094946A (ja) | 2014-05-22 |
CA2712087A1 (en) | 2009-07-30 |
KR20100105778A (ko) | 2010-09-29 |
BRPI0906504A2 (pt) | 2015-07-14 |
JP5936821B2 (ja) | 2016-06-22 |
AU2009206566A1 (en) | 2009-07-30 |
US20170035757A1 (en) | 2017-02-09 |
JP5881671B2 (ja) | 2016-03-09 |
PT2237783E (pt) | 2014-12-23 |
US9763944B2 (en) | 2017-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2009000529A1 (en) | Methods and compositions for treating allergic diseases | |
MX2012001974A (es) | Compuestos de biarilo y metodos de uso de los mismos. | |
PH12015501806B1 (en) | Novel benzopyran kinase modulators | |
MX2011007930A (es) | Conjugados de insulina cristalina. | |
TW200736275A (en) | Methods and compositions for treating allergic diseases | |
PH12014501736B1 (en) | Therapeutic use of p75ntr neurotrophin binding protein | |
GEP20135898B (en) | Rifaximin forms and usage | |
MY173616A (en) | Compositions and methods for lowering triglycerides | |
TW200745109A (en) | Pyrrolo-pyridine kinase modulators | |
PH12015501955B1 (en) | Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases | |
EA200701995A1 (ru) | Способы уменьшения кальцификации | |
DK3135672T3 (da) | Sammensætninger og fremgangsmåder til behandling af alkoholforbrugslidelser, smerter og andre sygdomme | |
IN2012DN02471A (es) | ||
WO2012086991A3 (ko) | 광 치료장치 및 이의 제어방법 | |
MY150931A (en) | Substituted oxazolidinones and their use | |
EA201190312A1 (ru) | Замещенные пиперидины | |
MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
MX2010008994A (es) | Combinacion que comprende paclitaxel para el tratamiento del cancer de ovario. | |
UA103468C2 (ru) | Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н3 | |
UA107576C2 (ru) | Замещенные пиперидины | |
MY157007A (en) | Novel possibility of controlling giardiosis | |
UA103197C2 (uk) | Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами | |
MX2010008103A (es) | Metodo para optimizar el tratamiento de enfermedades proliferativas mediadas por el receptor de cinasa de tirosina kit con imatinib. | |
WO2009105507A3 (en) | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain | |
ZA200705490B (en) | Substituted benzimidazoles for treatment of histomoniasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |